Sherman Oaks, California Clinical Trials

A listing of Sherman Oaks, California clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1558 clinical trials
featured
A Study Evaluating Safety and Tolerability and Pharmacokinetics of Navitoclax Monotherapy and in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasm

www.myelofibrosisresearch.com There are 4 parts to this study for which the primary objectives are to evaluate safety, tolerability, and pharmacokinetics (PK) of navitoclax when administered alone (Part 1) or when administered in combination with ruxolitinib (Part 2). In Part 2, participants must have been receiving a stable dose of ruxolitinib …

stem cell transplantation
leukemia
thrombocytosis
essential thrombocythemia
ruxolitinib
UCLA /Id# 222784
 (5.4 away) Contact site
  • 1 views
  • 01 Sep, 2021
  • +36 other locations
featured
C2541013 MIRNA NASH  

The study aims to evaluate two, orally administered, investigational agents - PF-06865571 (DGAT2 inhibitor) and the coadministration of PF-06865571 with PF-05221304 (ACC inhibitor). This study is specifically designed to evaluate the effect of a range of doses of DGAT2i alone, and DGAT2i + ACCi, on resolution of NASH or improvement …

ASCLEPES Research Centers, P.C.
 (5.3 away)
  • 308 views
  • 31 Aug, 2021
  • +61 other locations
featured
C3671008 Matisse

This randomized, double-blinded, placebo-controlled Phase 3 study is designed to evaluate the efficacy and safety of maternal immunization with RSVpreF against medically attended lower respiratory tract illness (MA-LRTI) in infants.

University Of California - Los Angeles
 (5.4 away) Contact site
  • 136 views
  • 16 Sep, 2021
  • +159 other locations
featured
C1071003 MagnetisMM-3

The purpose of the study is to evaluate whether single-agent PF-06863135 can provide clinical benefit in participants with relapsed/refractory multiple myeloma. PF-06863135 is a bispecific antibody: binding of PF-06863135 to CD3-expressing T-cells and BCMA-expressing multiple myeloma cells causes targeted T-cell-mediated cytotoxicity.

refractory multiple myeloma
Beverly Hills Cancer Center
 (6.9 away) Contact site
  • 1 views
  • 15 Sep, 2021
  • +3 other locations
featured
ECOSPOR III: A Phase 3 Multicenter, RandomizeEd, Double Blind, Placebo COntrolled, Parallel Group Study to Evaluate the Safety, Tolerability, & Efficacy of SER-109 vs. Placebo to Reduce Recurrence of ClOstRidium Difficile Infection (CDI) in Adults

ECOSPOR III is a Phase 3, multicenter, randomized, double-blind, placebo-controlled, parallel-group study of the safety, tolerability, and efficacy of SER-109 versus placebo in adult subjects 18 years of age or older with recurrent CDI, defined as: a history of ≥ 3 CDI episodes within 9 months, inclusive of the current …

fidaxomicin
antibiotic therapy
antibiotics
vancomycin
clostridium difficile
California Medical Research Associates Inc
 (8.1 away) Contact site
  • 1107 views
  • 21 Dec, 2020
  • +71 other locations
featured
A Phase 1b Study of INCMGA00012 in Combination With Other Therapies in Patients With Advanced Solid Tumors Carcinoma

The purpose of this study is to determine the safety, preliminary evidence of clinical activity, and recommended Phase 2 dose (RP2D) of INCMGA00012 in combination with other agents that may improve the therapeutic efficacy of anti-PD-1 monotherapy.

solid tumors
cancer
THE ANGELES CLINIC AND RESEARCH INSTITUTE
 (7.2 away) Contact site
  • 25 views
  • 14 Dec, 2020
  • +8 other locations
featured
[ONLINE] Genetic Testing for Common Disorders: Learning from the Experiences of Individuals who were Tested to Determine their Genetic Risk for Alzheimer’s Disease

This study is looking for people who have the APOE-e4 gene, which is associated with a higher risk for developing Alzheimer’s disease. The study is interested in learning about participants’ experiences. Contact Person Doris T. Zallen 540-231-4216dtzallen@vt.edu IMPORTANT: This communication is meant only to make you aware of an opportunity …

Online238
 (6.4 away) Contact site
  • 517 views
  • 17 Nov, 2020
  • +251 other locations
featured
[ONLINE] Dementia dogs: Their impact on community-dwelling persons with mild to moderate dementia

  This study is looking for pairs of participants: a person with mild-to-moderate dementia, and their caregiver. The study is interested in the difference that dogs can make in participants’ lives. Contact Person Frederic Dumont 1 418 529-9141 ext 6033frederic.dumont@cirris.ulaval.ca

moderate dementia
Online238
 (6.4 away) Contact site
  • 29 views
  • 12 Oct, 2020
  • +250 other locations
featured
[ONLINE] Daily Reflections of Dementia Caregivers

This study is looking for caregivers of family members who have mild cognitive impairment or dementia. This is a survey study that is interested in learning about caregivers’ experiences. Contact Person Dr. Carolyn Pickering 210-560-3075 pickeringc@uthscsa.edu Study Website:www.caregivingresearch.org/daily-reflections

Online238
 (6.4 away) Contact site
  • 98 views
  • 28 Jan, 2021
  • +252 other locations
featured
[ONLINE] Savonix Inc-Alzheimer’s Disease Discovery.

This study is looking for adults over the age of 22. This is an online cognitive study. Contact Person Reynald Hiole 415-919-7421 "mailto:rhiole@savonix.com"rhiole@savonix.com Click the link below to sign up https://www.assiststudy.org/

Online238
 (6.4 away) Contact site
  • 101 views
  • 28 Jan, 2021
  • +250 other locations